Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
0(0%)
Results Posted
100%(1 trials)
Terminated
1(20%)

Phase Distribution

Ph phase_3
1
20%
Ph not_applicable
4
80%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution5 total trials
Phase 3Large-scale testing
1(20.0%)
N/ANon-phased studies
4(80.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

25.0%

1 of 4 finished

Non-Completion Rate

75.0%

3 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Completed(1)
Terminated(3)
Other(1)

Detailed Status

Withdrawn2
Terminated1
unknown1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
50.0%
Most Advanced
Phase 3

Trials by Phase

Phase 31 (20.0%)
N/A4 (80.0%)

Trials by Status

terminated120%
unknown120%
withdrawn240%
completed120%

Recent Activity

Clinical Trials (5)

Drug Details

Intervention Type
DRUG
Total Trials
5